Roblitinib
Roblitinib (FGF-401) is a selective FGFR4 inhibitor with antineoplastic potential. It suppresses tumor cell proliferation in FGFR4-overexpressing models and is used in research targeting hepatocellular carcinoma and other solid tumors, both in vitro and in vivo.
Product Specifications
CAS Number
1708971-55-4
Product Name Alternative
JHH, JHH7, inhibit, Inhibitor, HUH7, FGF 401, FGFR, FGF401, FGF-401, FGFR4, Fibroblast growth factor receptor, Hep3B, HEPG2, C552A, Roblitinib
Field of Research
Cardiovascular Research, Signal Transduction
Purity
97.27% (May vary between batches)
Solubility
Ethanol:0.83 mg/mL (1.64 mM) ; DMSO:2 mg/mL (3.95 mM)
Smiles
COCCNc1cc (NC (=O) N2CCCc3cc (CN4CCN (C) CC4=O) c (C=O) nc23) ncc1C#N
Molecular Formula
C25H30N8O4
Molecular Weight
506.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS957929-05 0.02 mg (Baculovirus)
Recombinant Goat Osteocalcin (BGLAP)
Sign In for Pricing
View Details